Get the Stockscreener App
4.327
7.54%
-0.353
After Hours:
4.33
0.003
+0.07%
Serina Therapeutics Inc stock is traded at $4.327, with a volume of 66,926.
It is down -7.54% in the last 24 hours and down -17.34% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$4.68
Open:
$4.61
24h Volume:
66,926
Relative Volume:
0.71
Market Cap:
$44.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-14.99%
1M Performance:
-17.34%
6M Performance:
-25.23%
1Y Performance:
-32.55%
1-Day Range:
$4.327
$4.74
1-Week Range:
$4.327
$5.06
52-Week Range:
$3.81
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
4.327 | 49.31M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
Is Serina Therapeutics Inc. stock a defensive play amid uncertaintyQuarterly Market Review & Daily Price Action Insights - newser.com
How Serina Therapeutics Inc. stock moves in volatile trading sessionsJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Why Serina Therapeutics Inc. (2BO) stock benefits from AI revolutionRisk Management & Technical Pattern Alert System - newser.com
Market reaction to Serina Therapeutics Inc.’s recent news2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Serina Therapeutics Provides Regulatory Update on SER-252 Program - The Globe and Mail
What market sentiment indicators show for Serina Therapeutics Inc. stockQuarterly Portfolio Report & Long-Term Capital Growth Strategies - newser.com
Serina Therapeutics Stock Slumps Pre-Market After FDA Places Hold On Application To Initiate Clinical Trials For Experimental Therapy - Stocktwits
Will Serina Therapeutics Inc. stock maintain growth storyPrice Action & Stepwise Entry and Exit Trade Signals - newser.com
Why Serina Therapeutics Inc. stock is favored by hedge fundsIPO Watch & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-11-03 07:02:38 - newser.com
Serina Therapeutics Inc. stock momentum explainedSwing Trade & High Conviction Investment Ideas - newser.com
Serina Therapeutics says US FDA places clinical hold on SER-252 program - MarketScreener
Serina Therapeutics says FDA places clinical hold on IND for SER-252 - TipRanks
Why Is Serina Therapeutics Stock Falling In Pre-market? - Nasdaq
Serina Therapeutics, Inc. Provides Regulatory Update on SER-252 Program - TradingView
Published on: 2025-11-03 05:07:19 - newser.com
Serina (NYSE American: SER) says FDA holds SER-252 IND; excipient data requested - Stock Titan
What candlestick patterns are forming on Serina Therapeutics Inc.M&A Rumor & Fast Entry High Yield Stock Tips - newser.com
Is a relief rally coming for Serina Therapeutics Inc. holders2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Published on: 2025-11-03 02:40:05 - newser.com
Earnings visualization tools for Serina Therapeutics Inc.Quarterly Portfolio Review & Daily Profit Focused Screening - newser.com
How Serina Therapeutics Inc. (2BO) stock valuation compares with sectorChart Signals & Entry Point Confirmation Alerts - newser.com
Serina Therapeutics Inc. stock chart pattern explained2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Will Serina Therapeutics Inc. stock outperform growth indexesMarket Movement Recap & Technical Entry and Exit Tips - newser.com
How geopolitical risks impact Serina Therapeutics Inc. (2BO) stockTrade Ideas & Free Safe Entry Trade Signal Reports - newser.com
Why Serina Therapeutics Inc. is moving todayMarket Performance Summary & Community Consensus Picks - newser.com
Why Serina Therapeutics Inc. (2BO) stock is listed among top recommendationsWeekly Market Report & High Accuracy Investment Signals - newser.com
Is Serina Therapeutics Inc. stock supported by free cash flowMarket Volume Summary & Low Risk Profit Maximizing Plans - newser.com
Technical signs of recovery in Serina Therapeutics Inc.Trade Analysis Summary & Technical Confirmation Trade Alerts - newser.com
What Wall Street predicts for Serina Therapeutics Inc. stock price - newser.com
What MACD trends signal for Serina Therapeutics Inc. stockWatch List & Free Expert Verified Stock Movement Alerts - newser.com
Why Serina Therapeutics Inc. (2BO) stock could outperform next year2025 Price Momentum & AI Based Trade Execution Alerts - newser.com
Automated trading signals detected on Serina Therapeutics Inc.2025 Top Gainers & Fast Gaining Stock Reports - newser.com
How Serina Therapeutics Inc. stock performs in stagflationJuly 2025 Breakouts & Reliable Volume Spike Alerts - newser.com
Using R and stats models for Serina Therapeutics Inc. forecastingJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Serina Therapeutics Inc Stock (SER) Financials Data
There is no financial data for Serina Therapeutics Inc (SER). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Cap:
|
Volume (24h):